Average cost of multi drug-resistant tuberculosis treatment in Afghanistan
Afghanistan: Average cost of multi drug-resistant tuberculosis treatment was 1,000 constant 2022 US$ in 2024. ▼ Falling
Average cost of multi drug-resistant tuberculosis treatment in Afghanistan, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
Afghanistan recorded 1,000 constant 2022 US$ for average cost of multi drug-resistant tuberculosis treatment in 2024. That is the lowest value across all 8 years on record.
Compared with earlier readings it is down 28.6% over ten years.
Afghanistan ranks 48th of 92 countries on this measure, in the middle of the range.
Average cost of multi drug-resistant tuberculosis treatment in Afghanistan, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 1,400 constant 2022 US$ | — |
| 2018 | 1,500 constant 2022 US$ | +7.1% |
| 2019 | 1,000 constant 2022 US$ | -33.3% |
| 2020 | 1,000 constant 2022 US$ | +0.0% |
| 2021 | 1,000 constant 2022 US$ | +0.0% |
| 2022 | 1,000 constant 2022 US$ | +0.0% |
| 2023 | 1,000 constant 2022 US$ | +0.0% |
| 2024 | 1,000 constant 2022 US$ | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,300 constant 2022 US$ | 1,000 constant 2022 US$ | 1,500 constant 2022 US$ | 3 |
| 2020s | 1,000 constant 2022 US$ | 1,000 constant 2022 US$ | 1,000 constant 2022 US$ | 5 |
Countries ranked near Afghanistan
More health data for Afghanistan
- Un projection of annual infant deaths, annual growth rate -1.45 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 812.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 14,735 deaths (2100)
- Population ages 65-69, male, annual growth rate 3.95 % change on previous year (2025)
- Population ages 65-69, male, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 65-69, male, per capita 0.0046 units per person (2025)
- Population ages 70-74, female, annual growth rate 3.95 % change on previous year (2025)
- Population ages 70-74, female, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 70-74, female, per capita 0.0039 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Afghanistan?
- Average cost of multi drug-resistant tuberculosis treatment in Afghanistan was 1,000 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Afghanistan?
- The highest recorded value was 1,500 constant 2022 US$ in 2018.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Afghanistan?
- The lowest recorded value was 1,000 constant 2022 US$ in 2019.
- How does Afghanistan rank for average cost of multi drug-resistant tuberculosis treatment?
- Afghanistan ranks 48th out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Afghanistan?
- Over the last ten years it is down 28.6%. The long-run trend across the full record is falling.
- Where does this Afghanistan data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.